المؤلفون: Koh Vcy, Tan Bkt, Ong Kw, Lee Jy, Puay Hoon Tan, S.F. Wong, Nur Diyana Md Nasir, Tan Ph, Jing Quan Lim, Liu W, Chow Yin Wong, Aye Aye Thike, Lian Dwq, Tan Vkm, Benjamin Nathanael Loke, Preetha Madhukumar, Ho Gh, Rajasegaran, Ng Gxp, Bin Tean Teh, Peiyong Guan, Ng Ccy, Chang Kte, Wei Sean Yong, Mihir Gudi

المصدر: The Journal of pathologyReferences. 249(4)

مصطلحات موضوعية: 0301 basic medicine, DNA Mutational Analysis, Breast Neoplasms, MAP3K1, medicine.disease_cause, Pathology and Forensic Medicine, MED12, Pathogenesis, Diagnosis, Differential, 03 medical and health sciences, 0302 clinical medicine, Mutation Rate, SETD2, Phyllodes Tumor, Predictive Value of Tests, Biomarkers, Tumor, FLNA, Medicine, Humans, Genetic Predisposition to Disease, Fibroepithelial neoplasms, Retrospective Studies, Mutation, business.industry, Gene Expression Profiling, Cancer, medicine.disease, 030104 developmental biology, Phenotype, Fibroadenoma, 030220 oncology & carcinogenesis, Cancer research, Female, Neoplasm Grading, business, Transcriptome

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580e7ece21ae5c1167b365cf4967bc77
https://pubmed.ncbi.nlm.nih.gov/31411343

المؤلفون: Tan, J, Ong, CK, Lim, WK, Ng, CCY, Thike, AA, Ng, LM, Rajasegaran, V, Myint, SS, Nagarajan, S, Thangaraju, S, Dey, S, Nasir, NDM, Wijaya, GC, Lim, JQ, Huang, DC, Li, ZM, Wong, BH, Chan, JYS, McPherson, JR, Cutcutache, I, Poore, G, Tay, ST, Tan, WJ, Putti, TC, Ahmad, BS, Iau, P, Chan, CW, Tang, APH, Yong, WS, Madhukumar, P, Ho, GH, Tan, VKM, Wong, CY, Hartman, M, Ong, KW, Tan, BKT, Rozen, SG, Tan, P, Tan, PH, Teh, BT

المصدر: Nature genetics. 47(11):1341

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:132348376

المؤلفون: Guan P; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Republic of Singapore., Chen J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Mo C; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China., Fukawa T; Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Zhang C; Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, P. R. China., Cai X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Li M; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Hong JH; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Republic of Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore., Ng CCY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Lee JY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Wong SF; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Liu W; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Zeng X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Wang P; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Xiao R; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Rajasegaran V; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Myint SS; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Lim AMS; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Tan PH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore.; Division of Pathology, Singapore General Hospital, Singapore, Republic of Singapore.; Luma Medical Centre, Singapore, Republic of Singapore., Ong CK; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore, Republic of Singapore., Xu T; Department of Urology, Peking University People's Hospital, Beijing, 100044, China., Du Y; Department of Urology, Peking University People's Hospital, Beijing, 100044, China., Bai F; Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking University, Beijing, 100871, China., Yao X; Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, P. R. China. yaoxin@tjmuch.com., Teh BT; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg., Tan J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. tanjing@sysucc.org.cn.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore. tanjing@sysucc.org.cn.; Hainan Academy of Medical Science, Hainan Medical University, Haikou, PR China. tanjing@sysucc.org.cn.

المصدر: EMBO molecular medicine [EMBO Mol Med] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

المؤلفون: Tan QX; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Shannon NB; Department of Head and Neck Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Lim WK; SingHealth Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Singapore.; Cancer and Stem Biology Program, Duke-NUS Medical School, Singapore, Singapore., Teo JX; SingHealth Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Singapore., Yap DRY; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Lek SM; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tan JWS; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tan SJJ; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Hendrikson J; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Liu Y; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Ng G; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Chong CYL; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Guo W; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Koh KKN; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Ng CCY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Rajasegaran V; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Wong JSM; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore., Seo CJ; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore., Ong CK; Cancer and Stem Biology Program, Duke-NUS Medical School, Singapore, Singapore.; Lymphoma Genomics Translational Laboratory, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Pathology Academic Clinical Program, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Teh BT; Cancer and Stem Biology Program, Duke-NUS Medical School, Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, ASTAR Research Entities, Singapore, Singapore., Kon OL; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Chia CS; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore., Soo KC; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore., Iyer NG; Department of Head and Neck Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Cancer and Stem Biology Program, Duke-NUS Medical School, Singapore, Singapore.; Cancer Therapeutics Research Laboratory, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Ong CJ; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, ASTAR Research Entities, Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jun 13; Vol. 14, pp. 1272432. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Hong JH; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore., Yong CH; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Department of Computer Science, National University of Singapore, Singapore., Heng HL; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore., Lau MC; Singapore Immunology Network, Agency for Science Technology and Research (A*STAR), Singapore.; Bioinformatics Institute (BII), Agency for Science Technology and Research (A*STAR), Singapore., Chen J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lee JY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Lim AH; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Li Z; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Guan P; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore., Chu PL; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore., Boot A; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore., Ng SR; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Yao X; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Wee FYT; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore., Lim JCT; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore., Liu W; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Wang P; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Xiao R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Zeng X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Sun Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Koh J; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore., Kwek XY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Ng CCY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Klanrit P; Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand.; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong., Lai J; Department of Pancreaticobiliary Surgery, Sun Yat-sen University, Guangzhou, China., Tai DWM; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore., Pairojkul C; Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Dima S; Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucuresti, Romania., Popescu I; Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucuresti, Romania., Hsieh SY; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Yu MC; Department of General Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Yeong J; Institute of Molecular and Cell Biology, Integrative Biology for Theranostics Lab, Agency for Science Technology and Research (A*STAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Pathology Academic Clinical Program, Duke-NUS Medical School, Singapore., Kongpetch S; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.; Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Jusakul A; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand., Loilome W; Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand.; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand., Tan P; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore.; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Tan J; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; State Key Laboratory of Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Teh BT; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore teh.bin.tean@singhealth.com.sg.; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Genome Institute of Singapore, Agency for Science Technology and Research (A*STAR), Singapore.; Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore.

المصدر: Gut [Gut] 2024 May 10; Vol. 73 (6), pp. 966-984. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Cholangiocarcinoma*/genetics , Cholangiocarcinoma*/metabolism , Cholangiocarcinoma*/drug therapy , Cholangiocarcinoma*/pathology , Bile Duct Neoplasms*/genetics , Bile Duct Neoplasms*/metabolism , Bile Duct Neoplasms*/pathology , Bile Duct Neoplasms*/drug therapy, Humans ; Animals ; Cell Line, Tumor ; Mice ; Gene Expression Profiling/methods ; Multiomics

المؤلفون: Hong JH; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore., Lim AH; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore., Kaewnarin K; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore., Chan JY; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore., Ng CCY; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore., Teh BT; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.

المصدر: Cancer discovery [Cancer Discov] 2024 Mar 01; Vol. 14 (3), pp. 392-395.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Developing Countries* , Neoplasms*/drug therapy , Neoplasms*/genetics, Humans ; Artificial Intelligence ; Global Health

المؤلفون: Meng J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Tan JYT; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Ye J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Xue Y; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Koh VCY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Wee F; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Tay TKY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Chan JY; National Cancer Centre Singapore, Singapore, Republic of Singapore., Ng CCY; National Cancer Centre Singapore, Singapore, Republic of Singapore., Iqbal J; Duke-NUS Medical School, Singapore, Republic of Singapore; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Lau MC; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore., Lim HE; National Cancer Centre Singapore, Singapore, Republic of Singapore., Toh HC; National Cancer Centre Singapore, Singapore, Republic of Singapore., Teh BT; National Cancer Centre Singapore, Singapore, Republic of Singapore., Dent RA; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore. Electronic address: rebecca.dent@singhealth.com.sg., Tan PH; KK Women's and Children's Hospital, Singapore, Republic of Singapore; Luma Women's Imaging Centre/Medical Centre, Singapore, Republic of Singapore. Electronic address: tanpuayhoon28@gmail.com., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Republic of Singapore; Duke-NUS Medical School, Singapore, Republic of Singapore; National Cancer Centre Singapore, Singapore, Republic of Singapore; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore. Electronic address: yeongps@imcb.a-star.edu.sg.

المصدر: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2024 Mar; Vol. 104 (3), pp. 100303. Date of Electronic Publication: 2023 Dec 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/metabolism, Humans ; Female ; Animals ; Mice ; CD8-Positive T-Lymphocytes ; Prognosis ; Programmed Cell Death 1 Receptor/metabolism ; Leukocytes, Mononuclear/metabolism ; Ligands ; Biomarkers/metabolism ; Lymphocytes, Tumor-Infiltrating ; B7-H1 Antigen/metabolism

المؤلفون: Jorns JM; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA., Farooq A; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA., Puzyrenko A; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA., Jarzembowski J; Department of Pathology, Children's Hospital of Wisconsin, Madison, WI, USA., Thike AA; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Nasir NDM; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Ng CCY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Liu W; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Lee JY; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Lim AH; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Guan P; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.; Quantitative Biology and Medicine Programme, Duke-NUS Medical School, Singapore., Teh BT; Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore., Tan PH; Luma Medical Centre, Singapore.; KK Women's and Children's Hospital, Singapore.; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Pathology, University of Western Sydney, Sydney, NSW, Australia.

المصدر: Histopathology [Histopathology] 2023 Sep; Vol. 83 (3), pp. 357-365. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

مواضيع طبية MeSH: Fibroadenoma*/genetics , Fibroadenoma*/pathology , Breast Diseases*/pathology , Breast Neoplasms*/pathology , Neoplasms, Fibroepithelial* , Fibroma*, Adolescent ; Humans ; Female ; beta Catenin ; Hyperplasia/genetics

SCR Disease Name: Pseudoangiomatous stromal hyperplasia

المؤلفون: Lim AH; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore., Low ZJ; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore., Shingate PN; Genome Institute of Singapore, A*STAR, Singapore, Singapore., Hong JH; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Chong SC; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore., Ng CCY; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore., Liu W; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore., Vaser R; Genome Institute of Singapore, A*STAR, Singapore, Singapore.; Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia., Šikić M; Genome Institute of Singapore, A*STAR, Singapore, Singapore.; Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia., Sung WK; Genome Institute of Singapore, A*STAR, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore., Nagarajan N; Genome Institute of Singapore, A*STAR, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore., Tan P; Genome Institute of Singapore, A*STAR, Singapore, Singapore. tanbop@gis.a-star.edu.sg.; Duke-NUS Medical School, Singapore, Singapore. tanbop@gis.a-star.edu.sg.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. tanbop@gis.a-star.edu.sg.; SingHealth/Duke-NUS Institute of Precision Medicine, Singapore, Singapore. tanbop@gis.a-star.edu.sg., Teh BT; SingHealth Duke-NUS Institute of Biodiversity Medicine, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.; Genome Institute of Singapore, A*STAR, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.; SingHealth/Duke-NUS Institute of Precision Medicine, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.; Institute of Molecular and Cell Biology, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.; National Cancer Center Singapore, Singapore, Singapore. teh.bin.tean@singhealth.com.sg.

المصدر: Communications biology [Commun Biol] 2022 Sep 15; Vol. 5 (1), pp. 967. Date of Electronic Publication: 2022 Sep 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Anthocyanins* , Orchidaceae*/genetics, Chromatin/metabolism ; Flowers/genetics ; Flowers/metabolism ; Gene Expression Regulation, Plant ; Glycosyltransferases/genetics ; Metabolic Networks and Pathways ; Singapore

المؤلفون: Lau MC; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Yi Y; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Cheung CCL; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Tan B; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Wee F; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Lee JN; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Lim X; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Lim CJ; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Leow WQ; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Lee JY; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Ng CCY; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Bashiri H; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore., Cheow PC; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Chan CY; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Koh YX; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore., Tan TT; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore., Kalimuddin S; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore., Tai WMD; National Cancer Centre Singapore, Division of Medical Oncology, Singapore, Singapore., Ng JL; Department of Colorectal Surgery, Singapore General Hospital, Singapore, Singapore., Low JG; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore., Lim TKH; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Liu J; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore.; Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

المصدر: Frontiers in immunology [Front Immunol] 2022 Sep 12; Vol. 13, pp. 978760. Date of Electronic Publication: 2022 Sep 12 (Print Publication: 2022).

نوع المنشور: Case Reports; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Carcinoma, Hepatocellular* , Liver Neoplasms*, Comorbidity ; Humans ; Immune Checkpoint Inhibitors ; Immunologic Memory ; Morbidity ; SARS-CoV-2 ; Transcriptome ; Tumor Microenvironment/genetics